IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $54.27 Consensus PT from Analysts
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been given an average recommendation of “Moderate Buy” by the fourteen brokerages that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been given an average recommendation of “Moderate Buy” by the fourteen brokerages that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to […]
